Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Esa Medika Mandiri Tbk. (EMMI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Esa Medika Mandiri Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Esa Medika Mandiri Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Esa Medika Mandiri Tbk. trades at Rp358 (market cap 620.46B, 8.41M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Esa Medika Mandiri Tbk. and UBC Medical Indonesia Tbk. are close in size by market cap, and Esa Medika Mandiri Tbk. is more actively traded (8.41M versus 843K). Which is the better fit depends on your goals.

EMMILABS
Market Cap
620.46B635.95B
Volume
8.41M843K
Lot
84.09K8.43K
Turnover
2.92B137.6M
Average Price
347.69163.22
Value
2.92B137.6M
Indicative Equilibrium Price
358165
Indicative Equilibrium Volume
3.01K246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EMMI
View details
LABS
View details

About Esa Medika Mandiri Tbk.

PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.

Read more on EMMI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS